Autoimmune complications of chronic lymphocytic leukemia

Seminars in Oncology
Terry J Hamblin

Abstract

Autoimmune complications are common in chronic lymphocytic leukemia (CLL), occurring in up to a quarter of all patients during the course of the illness. By far the most common manifestation is autoimmune hemolytic anemia (AIHA), followed by immune thrombocytopenia (ITP). It is not true to say that autoimmunity is confined to the formed elements of the blood since conditions such as paraneoplastic pemphigus and acquired angioedema do occur in CLL, but nonhematologic autoimmunity is very rare indeed. The pathogenesis of autoimmunity in CLL is unknown. It may be related to the ability of the CLL cells to act as antigen-presenting cells (APCs), and to process antigen (particularly the Rh protein) so as to reveal cryptic peptides that are seen as foreign by helper T cells. It is likely that a failure of regulatory T-cell function is also involved. Autoimmune episodes may be triggered by treatment, particularly with purine analogues. Such episodes are often severe and may be fatal. Treatment of CLL-associated autoimmunity follows conventional protocols, but non-response to primary treatments is not uncommon. Promising results have been obtained with cyclosporine and rituximab.

Citations

Jan 1, 2009·Current Hematologic Malignancy Reports·Anders OsterborgJeanette Lundin
Jan 20, 2011·Clinical Reviews in Allergy & Immunology·Emanual MaverakisMiki Shirakawa Garcia
Oct 10, 2009·International Journal of Hematology·Satoshi HorinoShigeru Tsuchiya
Aug 30, 2008·British Medical Bulletin·A D Hamblin, T J Hamblin
Mar 14, 2007·Blood·Elizabeth S RavecheGerald E Marti
Apr 28, 2009·Blood·Douglas B CinesEline T Luning Prak
Jan 19, 2011·Haematologica·Kate HodgsonCarol Moreno
May 22, 2013·Clinical & Developmental Immunology·Giovanni D'ArenaPellegrino Musto
May 7, 2011·Advances in Hematology·Claudio Fozza, Maurizio Longinotti
Mar 28, 2008·Wiener klinische Wochenschrift·Peter Valent, Klaus Lechner
Jun 20, 2007·Leukemia & Lymphoma·Giovanni D'Arena, Nicola Cascavilla
Dec 22, 2010·Leukemia & Lymphoma·Giovanni D'Arena, Nicola Cascavilla
Jun 20, 2007·Leukemia & Lymphoma·Alexander W HauswirthUlrich Jäger
Feb 10, 2010·Leukemia & Lymphoma·Klaus Lechner, Yen-An Chen
May 24, 2012·Expert Opinion on Investigational Drugs·Lukáš Smolej
Feb 2, 2016·Autoimmunity·S Ju SmirnovaA B Sudarikov
Apr 5, 2016·Seminars in Oncology·Kerry A Rogers, Jennifer A Woyach
Sep 14, 2010·Seminars in Cancer Biology·Dalemari Crowther-Swanepoel, Richard S Houlston
Jul 24, 2010·Blood Reviews·George Garratty
Jul 14, 2010·Best Practice & Research. Clinical Haematology·Clive S Zent, Neil E Kay
Nov 26, 2009·Hematology/oncology Clinics of North America·Carlo Visco, Francesco Rodeghiero
May 19, 2009·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Zeynep Arzu YeginRauf Haznedar
Mar 31, 2009·Seminars in Hematology·Douglas B CinesRoberto Stasi
Oct 22, 2008·Leukemia Research·Terry J Hamblin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.